Pelitinib is widely utilized in research focused on:

• Cancer Treatment: Pelitinib is primarily studied for its potential in treating various types of cancer, particularly non-small cell lung cancer (NSCLC). Its targeted action on specific cancer cell pathways makes it a promising candidate for personalized medicine.
• Drug Development: Researchers are exploring Pelitinib as a lead compound for developing new anti-cancer drugs. Its unique structure allows for modifications that can enhance efficacy and reduce side effects compared to traditional chemotherapy agents.
• Combination Therapies: Pelitinib is being investigated in combination with other therapies to improve treatment outcomes. This approach can help overcome resistance mechanisms that often limit the effectiveness of single-agent treatments.
• Biomarker Research: The use of Pelitinib in clinical studies is aiding the identification of biomarkers that predict patient responses to treatment, which is crucial for optimizing therapy and improving patient outcomes.
• Pharmacokinetic Studies: Pelitinib's pharmacokinetic profile is being analyzed to understand its absorption, distribution, metabolism, and excretion in the body, providing valuable information for dosage optimization and safety assessments.